Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Potent structure

Optimization needs to be tempered by compromise. The most potent structure in vitro may be too polar, or too lipophilic, for delivery to the target in vivo. Compromise and drug selection may be achieved by developing an SAR for each desirable attribute. [Pg.102]

A Potent Structure Proof Technique Mass Spectrometry (Fast Atom Bombardment)... [Pg.58]

The emergence of potent structural technique such as EXAFS as well as the applicationn of UHV surface science techniques to catalytic problems has and will play a pivotal role in the development of a fundamental understanding of the science of catalysis. An enhanced understanding inevitably leads to scientific and technological breakthroughs. [Pg.11]

Sani, M., Candiani, G., Pecker, F., Malpezzi, L. and Zanda M. (2005) Novel highly potent, structurally simple y-trifluoromethyl y-sulfone hydroxamate inhibitor of stromelysin-1 (MMP-... [Pg.115]

To date, all attempts to synthesize more potent structural analogues of glutamate with herbiddal adivity failed despite the research efforts dedicated to the herbicide target glutamine synthetase [19]. [Pg.307]

Several computational methods can identify conformations that can be superimposed with a reasonable overlap of user-supplied pharmacophoric points in each molecule. In the active analog approach, several potent, structurally diverse ligands are submitted to a systematic conformational search while pharmacophore interpoint distances are recorded for each energetically allowed conformation. Intersection of the distance maps of these molecules identifies sets of conformations with common distances between the pharmacophoric points. [Pg.187]

To design more potent structures, steric and hydrogen bond features that enhance biological potency can be visualized in 3D by highlighting the optimal distances between molecular surfaces and sampling points. Ihe trained neural net directly forecasts the potency of new structures. [Pg.217]

Five potent and ultra-potent structurally diverse sweeteners which are believed to activate the aspartame receptor were selected as model templates. [Pg.2888]

Thus, UDD can be used in polymer composites as active filler and potent structure former increasing their strength, wear resistance, and heat resistance. This is due to record values of specific surface and, therefore, surface energy the presence of surface functional groups and high heat conduction. Also, owing to the sphericity of its particles UDD plays the role of dry lubricant decreasing the friction coefficient. [Pg.40]

Zhang and co-workers worked on the structure-based, computer-assisted search for low molecular weight, non-peptidic protein tyrosine phosphate IB (PTPIB) inhibitors, also using the DOCK methodology [89], They identified several potent and selective PTPIB inhibitors by saeening the ACD. [Pg.616]

An impressive example of the application of structure-based methods was the design of a inhibitor of the HIV protease by a group of scientists at DuPont Merck [Lam et al. 1994 This enzyme is crucial to the replication of the HIV virus, and inhibitors have bee shown to have therapeutic value as components of anti-AIDS treatment regimes. The star1 ing point for their work was a series of X-ray crystal structures of the enzyme with number of inhibitors boimd. Their objective was to discover potent, novel leads whid were orally available. Many of the previously reported inhibitors of this enzyme possessei substantial peptide character, and so were biologically unstable, poorly absorbed am rapidly metabolised. [Pg.707]

Another structural type is chromenes. Centchroman [31477-60-8]is a pyrrolidinoethoxyplienyl chromane which is a potent antiestrogen with weak estrogenic activity. In India, it is used as a weekly contraceptive pih based on its reported abiUty to inhibit the uterine preparation for the attachment of the fertilized ova to the wall of the utems (see Contraceptives) (31). [Pg.237]

In the pharmaceutical literature some pyrazoles fused to the prostaglandin structure are cited. Thus, 9,ll-azo-PGE2 (701), a stable endoperoxide analogue that is eight times as potent as PGG2, is a compound that specifically blocks TXA2 synthetase (79MI40401). [Pg.294]

Pseudopterosin A is a member of a group of marine natural products which show potent antiinflammatory properties, but which are not prostaglandin biosynthesis inhibitors. Structurally similar to phosphatidyl inositol, they may function as phospholipase inhibitors, and, as such, may be the forerunners of a new class of therapeutic agents. [Pg.237]

Whilst tropyltropine (atropine) is mydriatic, this property is of a low order in benz yltropine and is absent in benzoyl- -tropine. The former is a weak and the latter a potent local anaesthetic. This parallelism in the influence of the tropyl and benzoyl radicals in developing mydriatic and local aniesthetic action respectively, has been shown by von Braun and his co-workers to occur through an extensive series of hydroxyalkylamines in addition to tropine. Considerable modification may be made in the structure of tropine without impairing its capacity for yielding mydriatics anaesthetics. Thus von Braun, Muller and Rath found that e tropyl- and benzoyl-esters respectively of liomotropine (I) and of N-hydroxyalkylnortropanes (III) are comparable with atropine and tropacocaine (derived from tropine (II) and 4-tropine (II) ), respectively... [Pg.107]

Trachelantamine, according to Syrneva, has a weak atropine-like action and also produces local anaesthesia. Its hydrolytic product, trache-lantamidine, which is structurally identical with tsoretronecanol, yields a p-aminobenzoyl derivative of -which the crystalline hydrochloride, m.p. 230-2°, is said to be as potent a local anaesthetic as cocaine hydrochloride. The chloro- -heliotridane (p. 606) formed by the aetion of thionyl ehloride on trachelantamidine reacts with 6-methoxy-8-aminoquinoline to form 6-methoxy-8-(pseMdoheliotridylamino)-quinoline,... [Pg.614]

Farnesyl transferase from rat cells is a heterodimer consisting of a 48 kD u-snbnnit and a 46 kD /3-snbnnit. In the structure shown here, helices 2 to 15 of the u-snbnnit are folded into seven short coiled coils that together form a crescent-shaped envelope partially surrounding the /3-snbnnit. Twelve helices of the /3-snl> nnit form a novel barrel motif that creates the active site of the enzyme. Farnesyl transferase inhibitors, one of which is shown here, are potent suppressors of tumor growth in mice, but their value in humans has not been established. [Pg.278]

The structure of 1-739,749, a farnesyl transferase inhibitor that is a potent tumor growth suppressor. [Pg.278]

The structure of vitamin E in its most active form, o-tocopherol, is shown in Figure 18.38. a-Tocopherol is a potent antioxidant, and its function in animals and humans is often ascribed to this property. On the other hand, the molecular details of its function are almost entirely unknown. One possible role for... [Pg.606]

Compounds 111 having structural features of the dual cyclooxygenase (COX)/5-lipooxygenase (5-LO) inhibitor tepoxalin and the 5-LO inhibitor ABT-761 were prepared. Many of these hybrid compounds are potent COX and 5-LO inhibitors two compounds (111, r =McO, R = R" = R = H, R = NH2, R = Me and r = MeO, R = R = Me, R" = R = H, R = Cl) inhibited eicosanoid biosynthesis in an ex vivo assay, but neither improved on the main deficiency of tepoxalin, duration of 5-LO inhibitory activity (99BMCL979). Compounds 111 inhibit the production of arachidonic acid products associated with 5-lipoxygenase and cyclooxygenase and are useful in the treatment of inflammatory disorders (99USP5925769). [Pg.85]


See other pages where Potent structure is mentioned: [Pg.368]    [Pg.272]    [Pg.184]    [Pg.37]    [Pg.275]    [Pg.433]    [Pg.60]    [Pg.368]    [Pg.272]    [Pg.184]    [Pg.37]    [Pg.275]    [Pg.433]    [Pg.60]    [Pg.615]    [Pg.616]    [Pg.247]    [Pg.683]    [Pg.711]    [Pg.291]    [Pg.368]    [Pg.1080]    [Pg.160]    [Pg.318]    [Pg.327]    [Pg.301]    [Pg.105]    [Pg.75]    [Pg.303]    [Pg.519]    [Pg.824]    [Pg.368]    [Pg.40]    [Pg.346]    [Pg.209]    [Pg.53]    [Pg.147]   
See also in sourсe #XX -- [ Pg.436 , Pg.437 ]




SEARCH



Potent

Potent structural variations

Potentization

© 2024 chempedia.info